Fetal Heart Diameter as a Predictor of Hemoglobin Bart Disease at Midpregnancy

Chinapa Nattawongsiri1, Fuanglada Tongprasert1, Theera Tongsong1

  • 1Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Insights

Fetal heart diameter (HD) effectively predicts hemoglobin Bart disease in fetuses at midpregnancy. Measurements using HD z-scores or actual values offer reliable noninvasive prenatal screening for fetal cardiomegaly.

Area of Science:

  • Maternal-fetal medicine
  • Prenatal diagnostics
  • Genetics

Background:

  • Hemoglobin Bart disease is a severe genetic disorder.
  • Early detection in mid-pregnancy is crucial for management.
  • Fetal heart abnormalities can be indicators of genetic conditions.

Purpose of the Study:

  • To assess the efficacy of fetal heart diameter (HD) in predicting fetal hemoglobin (Hb) Bart disease.
  • To establish reliable ultrasound-based markers for prenatal screening.

Main Methods:

  • Retrieved and analyzed video clips of fetal chest ultrasounds (18-22 weeks gestation).
  • Measured fetal HD and converted measurements to z-scores.
  • Evaluated HD z-scores and actual HD values against the 95th percentile for prediction, using ROC curves to determine optimal cutoffs.

Main Results:

  • An HD z-score > 2 showed 94.6% sensitivity and 84.9% specificity.
  • An actual HD > 95th percentile demonstrated 100% sensitivity but 69.8% specificity.
  • Optimal cutoffs were HD z-score of 2.27 and actual HD of 18.15 mm, yielding high sensitivity and specificity.

Conclusions:

  • Fetal HD is a highly effective predictor of Hb Bart disease in at-risk fetuses during mid-pregnancy.
  • Both HD z-scores and actual HD measurements serve as valuable noninvasive tools for prenatal screening of fetal cardiomegaly.
Abstract